Australia Connected Drug Delivery Devices Market Size & Outlook
Australia connected drug delivery devices market, 2018-2030 (US$M)
Related Markets
Australia connected drug delivery devices market highlights
- The Australia connected drug delivery devices market generated a revenue of USD 172.4 million in 2022 and is expected to reach USD 901.4 million by 2030.
- The Australia market is expected to grow at a CAGR of 23% from 2023 to 2030.
- In terms of segment, parenteral was the largest revenue generating route of administration in 2022.
- Inhalational is the most lucrative route of administration segment registering the fastest growth during the forecast period.
Connected drug delivery devices market data book summary
| Market revenue in 2022 | USD 172.4 million |
| Market revenue in 2030 | USD 901.4 million |
| Growth rate | 23% (CAGR from 2022 to 2030) |
| Largest segment | Parenteral |
| Fastest growing segment | Inhalational |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhalational, Parenteral |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S ADR, Medtronic PLC, Adherium Ltd, Tandem Diabetes Care Inc, Propeller Health, Ypsomed Holding AG, AptarGroup Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 3.6% of the global connected drug delivery devices market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan connected drug delivery devices market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 865.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Connected Drug Delivery Devices Market Scope
Connected Drug Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia connected drug delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to connected drug delivery devices market will help companies and investors design strategic landscapes.
Parenteral was the largest segment with a revenue share of 56.32% in 2022. Horizon Databook has segmented the Australia connected drug delivery devices market based on inhalational, parenteral covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia connected drug delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia connected drug delivery devices market databook
-
Our clientele includes a mix of connected drug delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia connected drug delivery devices market, including forecasts for subscribers. This country databook contains high-level insights into Australia connected drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia connected drug delivery devices market size, by route of administration, 2018-2030 (US$M)
Australia Connected Drug Delivery Devices Market Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
